Sienna Biopharmaceuticals, Inc. Operating Cash Flow
Sienna Biopharmaceuticals, Inc. reported Operating Cash Flow of -$39.03 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2019-11-12
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$17.84M.
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$8.42M.
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$12.77M.
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-12-31 was -$15.60M.
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$61.69M.
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$41.01M.
- Sienna Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$17.61M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$17.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$26.26M derived: sum of 2 quarters · filed 2019-11-12 | -$39.03M 10-Q · filed 2019-11-12 | -$54.63M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | -$8.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$21.19M 10-Q · filed 2019-08-08 | -$36.78M derived: sum of 3 quarters · filed 2019-08-08 | -$52.67M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | -$12.77M 10-Q · filed 2019-05-08 | -$28.37M derived: sum of 2 quarters · filed 2019-05-08 | -$44.26M derived: sum of 3 quarters · filed 2019-11-12 | -$60.01M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-12-31 | -$15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$31.49M derived: sum of 2 quarters · filed 2019-11-12 | -$47.24M derived: sum of 3 quarters · filed 2019-11-12 | -$61.69M 10-K · filed 2019-03-14 |
| 2018-09-30 | -$15.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$31.64M derived: sum of 2 quarters · filed 2019-11-12 | -$46.09M 10-Q · filed 2019-11-12 | -$60.17M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$15.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$30.20M 10-Q · filed 2019-08-08 | -$44.29M derived: sum of 3 quarters · filed 2019-08-08 | -$53.69M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$14.46M 10-Q · filed 2019-05-08 | -$28.54M derived: sum of 2 quarters · filed 2019-05-08 | -$37.94M derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$14.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$23.48M derived: sum of 2 quarters · filed 2019-03-14 | -$41.01M 10-K · filed 2019-03-14 | |
| 2017-09-30 | -$9.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$26.93M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$17.53M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | -$17.61M 10-K · filed 2019-03-14 |